focus -WSS

focus

author：knowledge 2025-10-01 00:48:04 - browse：88

-- health policy coverage from STAT — Protestors outside America's Health Insurance Plans headquarters. Courtesy People's Action

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans.

The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the summer. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

People’s Action has worked with high-profile progressive lawmakers, including Sen. Elizabeth Warren (D-Mass.), to push for lower drug prices and Medicare for All.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Readout LOUD podcast: A CRISPR milestone, biotech mixology

hotspot

entertainment

WSS

Flagship Pioneering startup Sonata Therapeutics lays off 21

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

FDA's Woodcock to retire early next year

A new drug could help frostbite victims avoid its ravages

Flagship Pioneering startup Sonata Therapeutics lays off 21

Wikipedia

focus

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Reporting on presidential health from Reagan to Trump and Biden

At least 13 dead in Texas as scorching temps continue

Flagship Pioneering startup Sonata Therapeutics lays off 21

The cancer drug shortage isn’t new — and neither are the solutions

Flagship Pioneering startup Sonata Therapeutics lays off 21

23andMe had bad news about my health. I wish a person had delivered it

Morphosys mixed study results for blood cancer drug

New air purifier tech could be key to improving indoor air quality

Readout LOUD podcast: A CRISPR milestone, biotech mixology

entertainment

Surprise medical billing ban raises prices elsewhere

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

U.K. considers world's first use of meningitis vaccine to address gonorrhea

FDA warns medical device makers about rise in fabricated data

As AI regulations shape up, health tech startups beg for clarity

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

hotspot

focus

entertainment

focus